Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men
NCT03315325 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2017-10-23
Summary
The present study was designed to assess the responsiveness of the hypothalamic pituitary gonadal axis to kisspeptin administration with increasing age in men.
Conditions
- Sterility, Reproductive
Interventions
- BIOLOGICAL
-
Human kisspeptin-10 (metastin 45-54)
Kisspeptin-10 (metastin 45-54, Calbiochem, Darmstadt, Germany) is a potent HPG-axis stimulator and control reproduction.
Sponsors & Collaborators
-
Quaid-e-Azam University
lead OTHER
Principal Investigators
-
Shahab · Quaid-i-Azam University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-08-08
- Primary Completion
- 2014-08-10
- Completion
- 2015-03-05
Countries
- Pakistan
Study Locations
More Related Trials
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076 ·Status: COMPLETED ·Phase: NA
-
Study of Pituitary Size and Function in Familial Dwarfism of Sindh
NCT00004365 ·Status: COMPLETED
-
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
NCT03252353 ·Status: UNKNOWN ·Phase: PHASE3
-
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
NCT00455884 ·Status: COMPLETED
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Age-related Differences in Response to Pituitary Stimulation Tests
NCT04572139 ·Status: COMPLETED
-
Administration of Kisspeptin in Patients With Hyperprolactinemia
NCT02956447 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults
NCT01088399 ·Status: COMPLETED
-
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
NCT05493709 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
NCT00915954 ·Status: COMPLETED ·Phase: NA
-
The Nash-wo-Numa (Childhood Growth & Development) Study
NCT03647553 ·Status: COMPLETED
-
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
NCT03708523 ·Status: UNKNOWN
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
The Effect of Lixisenatide on the Effect of Pituitary Hormones
NCT05804513 ·Status: UNKNOWN ·Phase: PHASE4
-
Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
NCT01109017 ·Status: COMPLETED
-
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
NCT00234533 ·Status: COMPLETED ·Phase: PHASE3
-
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945 ·Status: COMPLETED ·Phase: NA
-
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
NCT04615273 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
NCT02310074 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
NCT01007071 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION